PALM BEACH, FLA.--( / ) September 09, 2016 -- For the first time in 1400 years, Muslim pilgrims can receive the Hajj sermons and announcements translated in real-time into seven (7) different languages thanks to a device invented by a Florida-based American Tech Firm, Divine Connect LLC. This technology will benefit over 70% of non-Arabic speakers on their annual pilgrimage to Makkah.
On September 10th, millions of Muslims will begin their Hajj journey. Hajj is the annual pilgrimage to the holy city of Makkah that Muslims are expected to make at least once in their lifetime. The Friday sermons at Masjid Al Haram in Makkah and Masjid Al Nabawi in Madinah have been delivered in the Arabic language only. Of the 1.6 billion Muslims worldwide, Arab Muslims constitute only 25% and it was difficult for non-Arabic speakers to understand the sermon and the announcements. It will be a different Hajj experience this time due to this new technology.
Talking about the technology Mohamed Sal Pazhoor, President & CTO of Divine Connect said, “A team of product designers and engineers have worked tirelessly for the last 3 years on creating this technology to support digital equipment that transmits real-time translations of the spoken Arabic into Urdu, English, Indonesian, French, Turkish, Hausa, and Persian languages, simultaneously.” He further mentioned that they are already working on adding more languages and their goal is to provide this service in 35 different languages.
“We have already done several tests of this technology and are very happy with the results. This is a historic breakthrough and we remain committed to providing excellent service to the 20 million pilgrims who visit Makkah annually,” Pazhoor said while speaking about the technology.
Divine Connect LLC, a Florida based firm, has invented this device that can receive these translated languages for the Hajj and Umrah pilgrims that don't speak Arabic. These new devices come in gold or silver color and will be sold online at and through retail distributors worldwide.
Additional information and interview requests contact Ms.Salma Khan.
View source version on businesswire.com:Korea Newswire distributes your news across every media channels through the industry’s largest press release distribution network
INGELHEIM, GERMANY--( / 야한여자사진 기프트 ) November 20, 2013 -- For media outside of the US, the UK & Canada only-- Boehringer Ingelheim has announced plans 성당면홀덤카페 복권판매사이트 to initiate two large, global 샤크툰 INGELHEIM,trials of 야한여자사진 메가밀리언당첨번호 Pradaxa® 성당면홀덤카페 숫자랜덤 (dabigatran etexilate) evaluating its efficacy and safety in stroke prevention therapy in 야한여자사진 복권당첨되는법 two 도아 INGELHEIM,highly relevant conditions.
The RE-SPECT ESUS™ trial will investigate the efficacy and safety of Pradaxa® in patients whose UKSS Thestroke was of 성당면홀덤카페 복건 embolic origin with unknown source (ESUS). Embolic strokes occur when a 야한여자사진 blood clot forms somewhere in the 성당면홀덤카페 body and travels through the bloodstream to the brain.1 The RE-DUAL PCI™ trial will evaluate the efficacy and safety of Pradaxa® 성당면홀덤카페 이웃수 in patients with non-valvular atrial fibrillation (NVAF) who have undergone percutaneous coronary intervention (PCI), also known as angioplasty, with stenting.
The 야한여자사진 로또액셀 trials are scheduled to begin enrolment in mid-2014 and respectively, early 2015 and will form part of the extensive RE-VOLUTION® clinical trial programme for 사야마아이 Thewhich will include 14 야한여자사진 즉석식복권스피또 clinical avril2day Theinvolving over 55,000 patients in more than 성당면홀덤카페 참을수없는성적유희 44 countries globally YURA Thethe two new trials are completed.2
“Pradaxa® was approved in 2010 to 야한여자사진 reduce the risk of stroke and 성당면홀덤카페 연금로또 systemic embolism in patients with atrial fibrillation, making it the first oral anticoagulant approved since warfarin was launched more than 50 years ago,” said Professor Klaus Dugi, Corporate Senior Vice President Medicine, Boehringer Ingelheim. “These plans for new trials reflect our confidence in the future of Pradaxa® and our 성당면홀덤카페 즉석복권판매 belief in its potential to benefit patient populations with the greatest unmet needs. We are hopeful 인스타그램 검색 “Pradaxa®results of the trials will 성당면홀덤카페 로또한장가격 provide greater understanding of Pradaxa®’s potential to reduce the risk of stroke and other life-threatening events for these patients.”
Higher rates of 야한여자사진 이예지성형전 morbidity and mortality are seen in 성당면홀덤카페 대박복권 patients suffering 인스타그램 검색 Higherrecurrent stroke after an ESUS.3,4 There is limited knowledge 인스타그램 검색 Higherdata 호빵넷TV Higherto guide 성당면홀덤카페 treatment decisions regarding secondary prevention of stroke in 성당면홀덤카페 하이로또복권방 these patients, resulting in considerable unmet need.5
The RE-SPECT ESUS™ trial (Randomized Evaluation in Secondary stroke Prevention Comparing the Thrombin inhibitor dabigatran etexilate versus ASA in Embolic Stroke of Undetermined Source) will be led by Professor Hans-Christoph Diener, Professor of Neurology and Chairman of the Department of Neurology, 성당면홀덤카페 고두림화보 University of Essen, AVWOW TheThe trial aims to include 야한여자사진 채보미고두림 6,000 patients who had an ESUS within three months of enrolment.
애틀랜타[1이닝득점] Detailed성당면홀덤카페 plans 성당면홀덤카페 야한여자사진 include: 성당면홀덤카페 로도박사
· Evaluating Pradaxa® compared to 채원님 ·acid 100 mg once daily (the current standard of care) for reduction of recurrent stroke. The majority of patients will receive Pradaxa® 150 mg twice daily. Patients aged 75 or 성당면홀덤카페 older 성당면홀덤카페 고두림얼짱시대캡쳐 or who 야한여자사진 로또복권수수료 have moderate renal impairment (CrCl 30-50 mL/min) will receive 야한여자사진 로또1등당첨비결 Pradaxa® 110 mg 야한여자사진 숫자6개 twice daily. 성당면홀덤카페 로또재테크
Research shows that patients with atrial fibrillation undergoing 성당면홀덤카페 ktx요금 PCI with stenting are at high risk of stroke and other major adverse cardiac events, which can be reduced by anticoagulation therapy.6 Currently, about one in every 10 patients 야한여자사진 권소현몸매 undergoing 성당면홀덤카페 소형비키니옷장 PCI with stenting 야한여자사진 권소현움짤 requires anticoagulant therapy to reduce their risk of stroke due to either AVMANY Researchfibrillation 야한여자사진 or other conditions.7
The RE-DUAL PCI™ trial (Randomized Evaluation of Dual Therapy with Dabigatran vs. Triple Therapy Strategy with Warfarin in Patients with NVAF that have undergone PCI 카지노롤렛 TheStenting) is planned to run in cooperation with Harvard 성당면홀덤카페 이케아비키니옷장 Clinical Research Institute (HCRI), led by Professor Christopher Cannon, M.D., cardiologist 나체촌 TheBrigham and Women’s Hospital in Boston and Professor of Medicine at 야한여자사진 Harvard Medical School in the US.
Detailed 성당면홀덤카페 고아라의찌라시블로그 야한여자사진 고아라의찌라시블로그 토렌트지니 Detailed성당면홀덤카페 섹시한산타 include: 성당면홀덤카페
· Event-driven trial will evaluate Pradaxa® 성당면홀덤카페 bikini라인노래 (150 mg or 110 야한여자사진 mg 성당면홀덤카페 김예스 twice daily) plus single antiplatelet therapy with 일본야동느낌 ·P2Y12 protein inhibitor, compared to the 성당면홀덤카페 클럽예스 current standard of care, which includes warfarin and two antiplatelet agents, to assess key outcomes of 오산성인용품종류 ·relevant bleeding and thrombotic events (defined as the combined rate of death, myocardial infarction 야한여자사진 김민정노출 and stroke) following PCI.
동양영계녀구매사이트 BoehringerIngelheim is committed to expanding scientific knowledge in stroke prevention 야한여자사진 황미희 and interventional cardiology with Pradaxa® - with an extensive and robust real-world 알맹이몰 Boehringerof 성당면홀덤카페 백지영노출콘서트 over 2 million patient years in all 성당면홀덤카페 백지영움짤 indications2 Pradaxa® has already established a safety and efficacy 야한여자사진 황정음노출화보 profile that 트레비TV Boehringermeaningful 성당면홀덤카페 구하라광고 clinical benefits to patients.
More 성당면홀덤카페 자이언트황정음노출 야한여자사진 자이언트황정음노출 원샷홀덤추천코드 More성당면홀덤카페 돈의화신황정음노출 야한여자사진 돈의화신황정음노출
|전화번호 :||영업시간 :|
|홈페이지 :||위치정보 :|
등록된 댓글이 없습니다.